Royalty Pharma (RPRX) News Today $31.79 +0.51 (+1.63%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$30.82 -0.97 (-3.05%) As of 08:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period California Public Employees Retirement System Sells 22,198 Shares of Royalty Pharma plc (NASDAQ:RPRX)California Public Employees Retirement System decreased its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 1.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,781,024 shares of the biopharmaceutical company's stockApril 4 at 4:14 AM | marketbeat.comAllstate Corp Makes New $299,000 Investment in Royalty Pharma plc (NASDAQ:RPRX)Allstate Corp bought a new stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 11,718 shares of the biopharmaceutical company's stock, valuedApril 4 at 4:12 AM | marketbeat.comPictet Asset Management Holding SA Trims Stake in Royalty Pharma plc (NASDAQ:RPRX)Pictet Asset Management Holding SA decreased its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 4.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 326,372 shares of the biopharmaceutical company's stock after sApril 4 at 3:55 AM | marketbeat.comTrexquant Investment LP Raises Position in Royalty Pharma plc (NASDAQ:RPRX)Trexquant Investment LP lifted its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 482.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 520,043 shares of the biopharmaceutical company's stock aApril 3 at 6:16 AM | marketbeat.comIs Royalty Pharma plc (RPRX) The Most Profitable Biotech Stock To Buy Right Now?April 2 at 10:30 AM | insidermonkey.comNorges Bank Takes Position in Royalty Pharma plc (NASDAQ:RPRX)Norges Bank purchased a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,880,346 shares of the biopharmaceutical compaApril 2 at 4:23 AM | marketbeat.comKorea Investment CORP Grows Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Korea Investment CORP grew its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 43.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 224,272 shares of the biopharmaceutical company's stock afterApril 2 at 4:07 AM | marketbeat.comIs Royalty Pharma Plc (RPRX) the Most Undervalued Healthcare Stock to Buy According to Analysts?April 1 at 10:36 AM | msn.comElo Mutual Pension Insurance Co Grows Holdings in Royalty Pharma plc (NASDAQ:RPRX)Elo Mutual Pension Insurance Co lifted its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 32.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,225 shares of tApril 1 at 4:13 AM | marketbeat.comBrandywine Global Investment Management LLC Raises Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Brandywine Global Investment Management LLC raised its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 7.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,958,302 shares of thMarch 31, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Holdings Lowered by Vanguard Group Inc.Vanguard Group Inc. decreased its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 0.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 37,354,009 shares of the biopharmaceutical company's stock after selling 231,114March 30, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Given Average Recommendation of "Buy" by AnalystsShares of Royalty Pharma plc (NASDAQ:RPRX - Get Free Report) have received an average rating of "Buy" from the six research firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, four have given a buy recommendation andMarch 29, 2025 | marketbeat.com4 Healthcare Stocks With Massive Gains—and More to Come (RPRX)Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year.March 29, 2025 | marketbeat.comSava Infond d.o.o. Acquires Shares of 21,000 Royalty Pharma plc (NASDAQ:RPRX)Sava Infond d.o.o. acquired a new stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 21,000 shares of the biopharmaceutical company's stoMarch 29, 2025 | marketbeat.comRoyalty Pharma pullback a buying opportunity, says CitiMarch 29, 2025 | markets.businessinsider.comFirst Week of RPRX May 16th Options TradingMarch 28, 2025 | nasdaq.comStock Traders Buy High Volume of Put Options on Royalty Pharma (NASDAQ:RPRX)Royalty Pharma plc (NASDAQ:RPRX - Get Free Report) was the target of unusually large options trading activity on Thursday. Stock traders bought 4,237 put options on the stock. This represents an increase of 344% compared to the typical daily volume of 954 put options.March 28, 2025 | marketbeat.comBank of America Securities Remains a Buy on Royalty Pharma (RPRX)March 28, 2025 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Royalty Pharma (RPRX)March 28, 2025 | markets.businessinsider.comHomestead Advisers Corp Purchases 73,000 Shares of Royalty Pharma plc (NASDAQ:RPRX)Homestead Advisers Corp boosted its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 3.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,931,140 shares of the biopharmaceutical company's stock afMarch 28, 2025 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Sees Strong Trading Volume - Should You Buy?Royalty Pharma (NASDAQ:RPRX) Sees Large Volume Increase - What's Next?March 27, 2025 | marketbeat.com3 Reasons to Sell RPRX and 1 Stock to Buy InsteadMarch 27, 2025 | msn.comRoyalty Pharma Announces Upcoming Investor DayMarch 27, 2025 | globenewswire.comMitsubishi UFJ Trust & Banking Corp Reduces Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Mitsubishi UFJ Trust & Banking Corp cut its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 6.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,869,142 sharesMarch 27, 2025 | marketbeat.comKLP Kapitalforvaltning AS Acquires Shares of 123,300 Royalty Pharma plc (NASDAQ:RPRX)KLP Kapitalforvaltning AS bought a new position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 123,300 shares of the biopharmaceutical company's stocMarch 27, 2025 | marketbeat.comCorient Private Wealth LLC Raises Stake in Royalty Pharma plc (NASDAQ:RPRX)Corient Private Wealth LLC boosted its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 86.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 46,249 shares of the biopharmaceutical company's stock after buMarch 27, 2025 | marketbeat.comVirtu Financial LLC Acquires New Position in Royalty Pharma plc (NASDAQ:RPRX)Virtu Financial LLC acquired a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 18,320 shares of the biopharmaceutical companyMarch 26, 2025 | marketbeat.comTeacher Retirement System of Texas Raises Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Teacher Retirement System of Texas grew its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 11.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 115,392 shares of the biopharmaceutical companMarch 26, 2025 | marketbeat.comIs Royalty Pharma plc (RPRX) The Best Defensive Stock Amid Market Volatility?March 25, 2025 | insidermonkey.comSciencast Management LP Makes New Investment in Royalty Pharma plc (NASDAQ:RPRX)Sciencast Management LP bought a new position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 39,132 shares of the biopharmaceutical company's stock,March 24, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Royal London Asset Management Ltd.Royal London Asset Management Ltd. boosted its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 10.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 177,695 sharesMarch 24, 2025 | marketbeat.comFox Run Management L.L.C. Increases Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Fox Run Management L.L.C. grew its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 41.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 55,062 shares of the biopharmaceutical company's stock after purchasing an addMarch 23, 2025 | marketbeat.comThrivent Financial for Lutherans Raises Position in Royalty Pharma plc (NASDAQ:RPRX)Thrivent Financial for Lutherans boosted its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 38.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 475,825 shares of the biopharmaceutical company's stock after bMarch 23, 2025 | marketbeat.comProficio Capital Partners LLC Takes Position in Royalty Pharma plc (NASDAQ:RPRX)Proficio Capital Partners LLC purchased a new stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 30,816 shares of the biopharmaceutical company's stock, valued at approximately $786,000. Other instiMarch 23, 2025 | marketbeat.comKoss Olinger Consulting LLC Invests $269,000 in Royalty Pharma plc (NASDAQ:RPRX)Koss Olinger Consulting LLC purchased a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 10,531 shares of the biopharmaceutical company's stock, valuedMarch 21, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Stake Lowered by HighTower Advisors LLCHighTower Advisors LLC decreased its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 5.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 173,411 shares of the biopharmaceutical company's stock aftMarch 20, 2025 | marketbeat.comTwin Tree Management LP Sells 29,820 Shares of Royalty Pharma plc (NASDAQ:RPRX)Twin Tree Management LP lowered its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 39.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,431 shares of the biopharmaceuticalMarch 19, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Stock Holdings Boosted by Horizon Kinetics Asset Management LLCHorizon Kinetics Asset Management LLC lifted its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 39.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 319,176 shares of the biopharmaceutical company's stock after acquiring an additionMarch 18, 2025 | marketbeat.comSwiss National Bank Trims Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Swiss National Bank decreased its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 5.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,076,100 shares of the biopharmaceutical company's stockMarch 18, 2025 | marketbeat.comRaymond James Financial Inc. Acquires Shares of 783,633 Royalty Pharma plc (NASDAQ:RPRX)Raymond James Financial Inc. bought a new stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 783,633 shares of the biopharmaceutical company's stock, valued at appMarch 17, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Position Trimmed by Tredje AP fondenTredje AP fonden decreased its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 50.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 51,175 shares of the biopharmaceutical company'sMarch 16, 2025 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Has $4.48 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX)Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 11.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 175,652 shares of the biopharmacMarch 15, 2025 | marketbeat.comAtria Investments Inc Sells 20,550 Shares of Royalty Pharma plc (NASDAQ:RPRX)Atria Investments Inc trimmed its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 47.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 22,633 shares of the biopharmaceutical coMarch 15, 2025 | marketbeat.comJupiter Asset Management Ltd. Purchases Shares of 194,036 Royalty Pharma plc (NASDAQ:RPRX)Jupiter Asset Management Ltd. purchased a new stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 194,036 shares of the biopharmaceutical company's stock, valuedMarch 14, 2025 | marketbeat.comAGF Management Ltd. Acquires Shares of 98,512 Royalty Pharma plc (NASDAQ:RPRX)AGF Management Ltd. purchased a new stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 98,512 shares of the biopharmaceutical company's stock, valued at approximately $2,513,000. Several other large invMarch 14, 2025 | marketbeat.comWealthfront Advisers LLC Has $4.82 Million Stake in Royalty Pharma plc (NASDAQ:RPRX)Wealthfront Advisers LLC boosted its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 1,655.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 188,935 shares of the biopharmaceMarch 13, 2025 | marketbeat.comRiver Road Asset Management LLC Sells 70,657 Shares of Royalty Pharma plc (NASDAQ:RPRX)River Road Asset Management LLC reduced its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 15.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 399,323 shares of the biopharmaceutical company'March 12, 2025 | marketbeat.comAmundi Sells 1,137,257 Shares of Royalty Pharma plc (NASDAQ:RPRX)Amundi cut its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 30.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,553,998 shares of the biopharmaceutical company's stock after seMarch 12, 2025 | marketbeat.comVictory Capital Management Inc. Boosts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Victory Capital Management Inc. raised its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 15.2% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 978,211 shares of the biopharmaceutical company's stock after purchasing an additionalMarch 11, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. increased its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 4.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,131,628 shares of the biopharMarch 11, 2025 | marketbeat.com Remove Ads Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address RPRX Media Mentions By Week RPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RPRX News Sentiment▼1.250.97▲Average Finance News Sentiment RPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RPRX Articles This Week▼177▲RPRX Articles Average Week Remove Ads Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Corcept Therapeutics News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Pacira BioSciences News Today Omeros News Today Nektar Therapeutics News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Eli Lilly and Company News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RPRX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Royalty Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RPRX Stock Free RPRX Stock Alerts